US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
TW333456B
(en)
*
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6149953A
(en)
*
|
1993-11-08 |
2000-11-21 |
Delta Food Group, Inc. |
Seeded microcapsules
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
ATE198152T1
(de)
*
|
1994-09-30 |
2001-01-15 |
Takeda Chemical Industries Ltd |
Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
|
IT1276690B1
(it)
*
|
1995-06-09 |
1997-11-03 |
Ira Srl |
Sistema di inclusione a rilascio controllato di acido glicolico in beta-ciclodestrine e procedimento di preparazione di detto sistema
|
TW448055B
(en)
*
|
1995-09-04 |
2001-08-01 |
Takeda Chemical Industries Ltd |
Method of production of sustained-release preparation
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
CA2192782C
(en)
*
|
1995-12-15 |
2008-10-14 |
Nobuyuki Takechi |
Production of microspheres
|
US6419961B1
(en)
|
1996-08-29 |
2002-07-16 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsules of a bioactive substance and a biodegradable polymer
|
EP0839525B1
(en)
*
|
1996-10-31 |
2004-08-04 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
AU7119398A
(en)
*
|
1997-04-16 |
1998-11-11 |
Mohammad W. Katoot |
Method and composition for targeted delivery of compounds
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US6106875A
(en)
*
|
1997-10-08 |
2000-08-22 |
Givaudan Roure (International) Sa |
Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
|
US6045835A
(en)
*
|
1997-10-08 |
2000-04-04 |
Givaudan Roure (International) Sa |
Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
|
NZ505163A
(en)
*
|
1997-12-26 |
2002-11-26 |
Yamanouchi Pharma Co Ltd |
Sustained release medicinal compositions comprising an ionic compound with an opposite charge to the ionic active substance
|
KR100595340B1
(ko)
|
1998-01-21 |
2006-07-03 |
다케다 야쿠힌 고교 가부시키가이샤 |
서방형 제제의 동결 건조법
|
DE19808634A1
(de)
*
|
1998-02-24 |
1999-08-26 |
Schering Ag |
Mantel für eine pharmazeutische Zusammensetzung
|
EA003101B1
(ru)
|
1998-03-19 |
2002-12-26 |
Бристол-Майерз Сквибб Компани |
Двухфазная система доставки с регулируемым высвобождением для фармацевтических средств с высокой растворимостью и способ лечения диабета с помощью этой системы
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US6565874B1
(en)
*
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
JP4473380B2
(ja)
*
|
1999-10-20 |
2010-06-02 |
小川香料株式会社 |
乾燥マイクロカプセルの製造方法
|
US6461631B1
(en)
|
1999-11-16 |
2002-10-08 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
TW200800298A
(en)
|
2000-01-27 |
2008-01-01 |
Zentaris Ag |
Compressed microparticles for dry injection
|
US20030124177A1
(en)
*
|
2000-04-26 |
2003-07-03 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
CN102327253A
(zh)
|
2000-04-26 |
2012-01-25 |
沃特森药物公司 |
最小化与奥昔布宁疗法有关的副作用
|
US7029694B2
(en)
|
2000-04-26 |
2006-04-18 |
Watson Laboratories, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US6676966B1
(en)
|
2000-05-09 |
2004-01-13 |
Intellipharmaceutics Corp. |
Extended release metformin hydrochloride formulations
|
AU2001269439A1
(en)
|
2000-07-05 |
2002-01-14 |
Takeda Chemical Industries Ltd. |
Medicinal preparations for treating sex hormone-dependent diseases
|
WO2002043580A2
(en)
|
2000-10-27 |
2002-06-06 |
Epic Therapeutics, Inc. |
Production of microspheres
|
US8470359B2
(en)
*
|
2000-11-13 |
2013-06-25 |
Qlt Usa, Inc. |
Sustained release polymer
|
FR2816840B1
(fr)
*
|
2000-11-17 |
2004-04-09 |
Flamel Tech Sa |
Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation
|
RU2203042C2
(ru)
*
|
2000-11-28 |
2003-04-27 |
Комиссарова Ирина Алексеевна |
Фармацевтическая композиция и способ ее получения
|
JP2004535431A
(ja)
|
2001-06-22 |
2004-11-25 |
サザン バイオシステムズ, インコーポレイテッド |
ゼロ次長期放出同軸インプラント
|
TW200526267A
(en)
|
2001-06-29 |
2005-08-16 |
Takeda Chemical Industries Ltd |
Controlled release composition and method of producing the same
|
JP5188670B2
(ja)
*
|
2001-06-29 |
2013-04-24 |
武田薬品工業株式会社 |
徐放性組成物およびその製造法
|
TWI225416B
(en)
*
|
2001-06-29 |
2004-12-21 |
Takeda Chemical Industries Ltd |
Sustained-release composition and process for producing the same
|
KR100521526B1
(ko)
|
2001-07-10 |
2005-10-13 |
캐논 가부시끼가이샤 |
폴리하이드록시알카노에이트로 이루어진 입상 구조체 및그 제조방법
|
US20080026068A1
(en)
*
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
ATE395042T1
(de)
*
|
2001-08-16 |
2008-05-15 |
Baxter Int |
Darreichungsformen welche mikropartikel und treibgas enthalten
|
US7812044B2
(en)
|
2001-11-13 |
2010-10-12 |
Takeda Pharmaceutical Company Limited |
Anticancer agents
|
EP2266590A3
(en)
|
2002-02-22 |
2011-04-20 |
Shire LLC |
Active agent delivery sytems and methods for protecting and administering active agents
|
EP1344520B1
(en)
*
|
2002-03-15 |
2007-10-03 |
Alrise Biosystems GmbH |
Microparticles and method for their production
|
ES2605402T3
(es)
*
|
2002-06-25 |
2017-03-14 |
Takeda Pharmaceutical Company Limited |
Procedimiento para producir una composición de liberación sostenida
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
AU2003299795A1
(en)
|
2002-12-20 |
2004-07-22 |
Xeris Pharmaceuticals, Inc. |
Intracutaneous injection
|
JP2007525429A
(ja)
*
|
2003-03-11 |
2007-09-06 |
キューエルティー ユーエスエー,インコーポレイテッド. |
細胞スケジュール依存性抗癌剤のための処方
|
JP2004331750A
(ja)
|
2003-05-02 |
2004-11-25 |
Canon Inc |
ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
DK1660039T3
(en)
|
2003-07-18 |
2017-01-16 |
Oakwood Laboratories L L C |
PREVENTION OF REDUCTION OF THE POLYMER MOLECULE WEIGHT, THE PREPARATION OF PURPOSES AND GELING IN POLYMER COMPOSITIONS
|
US8075919B2
(en)
*
|
2003-07-18 |
2011-12-13 |
Baxter International Inc. |
Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
AU2004258971A1
(en)
*
|
2003-07-22 |
2005-02-03 |
Baxter Healthcare S.A. |
Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
|
US20090214644A1
(en)
*
|
2003-07-31 |
2009-08-27 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations with reduced adverse effects
|
US20050025825A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Xanodyne Pharmacal, Inc. |
Tranexamic acid formulations with reduced adverse effects
|
TW200529890A
(en)
*
|
2004-02-10 |
2005-09-16 |
Takeda Pharmaceutical |
Sustained-release preparations
|
US20050245614A1
(en)
*
|
2004-03-04 |
2005-11-03 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations
|
US20050244495A1
(en)
|
2004-03-04 |
2005-11-03 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations
|
US8022106B2
(en)
*
|
2004-03-04 |
2011-09-20 |
Ferring B.V. |
Tranexamic acid formulations
|
US7947739B2
(en)
|
2004-03-04 |
2011-05-24 |
Ferring B.V. |
Tranexamic acid formulations
|
US20090215898A1
(en)
*
|
2004-03-04 |
2009-08-27 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations
|
ES2442115T3
(es)
|
2004-05-12 |
2014-02-10 |
Baxter International Inc. |
Microesferas que contienen oligonucleótidos, su utilización para la preparación de un medicamento para el tratamiento de la diabetes tipo 1
|
US8728525B2
(en)
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
ES2422757T3
(es)
|
2004-05-12 |
2013-09-13 |
Baxter Int |
Uso terapéutico de microesferas de ácido nucleico
|
CA2566075A1
(en)
|
2004-05-12 |
2005-12-01 |
Baxter Healthcare S.A. |
Microspheres comprising protein and showing injectability at high concentrations of said agent
|
AU2005264864B2
(en)
|
2004-06-16 |
2011-08-11 |
Takeda Pharmaceutical Company Limited |
Multiple PPI dosage form
|
TW200613012A
(en)
*
|
2004-07-02 |
2006-05-01 |
Takeda Pharmaceuticals Co |
Sustained-release composition, process for producing the same and use of the same
|
KR20070083941A
(ko)
*
|
2004-10-04 |
2007-08-24 |
큐엘티 유에스에이, 인코포레이티드 |
중합체 전달 조성을 갖는 눈 전달
|
US8313763B2
(en)
*
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
DK1824460T3
(en)
*
|
2004-11-10 |
2015-01-19 |
Tolmar Therapeutics Inc |
Stabilized polymeric delivery system
|
CN101188996B
(zh)
*
|
2005-04-27 |
2013-03-27 |
巴克斯特国际公司 |
表面改性的微粒及其形成和使用方法
|
US8236759B2
(en)
*
|
2005-06-30 |
2012-08-07 |
Ipsen Pharma Sas |
GLP-1 pharmaceutical compositions
|
US8546451B2
(en)
|
2005-11-28 |
2013-10-01 |
Gtx, Inc. |
Estrogen receptor ligands and methods of use thereof
|
US8637706B2
(en)
|
2005-11-28 |
2014-01-28 |
Gtx, Inc. |
Nuclear receptor binding agents
|
US9409856B2
(en)
|
2005-11-28 |
2016-08-09 |
Gtx, Inc. |
Estrogen receptor ligands and methods of use thereof
|
US20070281031A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Guohan Yang |
Microparticles and methods for production thereof
|
US7964574B2
(en)
|
2006-08-04 |
2011-06-21 |
Baxter International Inc. |
Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
|
WO2008060786A2
(en)
*
|
2006-10-06 |
2008-05-22 |
Baxter International Inc. |
Microencapsules containing surface-modified microparticles and methods of forming and using the same
|
EP2236546B1
(en)
*
|
2006-10-31 |
2011-12-28 |
Surmodics Pharmaceuticals, Inc. |
Speronized polymer particles
|
US8628701B2
(en)
|
2006-10-31 |
2014-01-14 |
Xavier University Of Louisiana |
Method of micro-encapsulation
|
US8429613B2
(en)
*
|
2006-10-31 |
2013-04-23 |
Microsoft Corporation |
Stepping and application state viewing between points
|
MY148370A
(en)
|
2006-12-18 |
2013-04-15 |
Takeda Pharmaceutical |
Sustained-release composition and method for producing the same
|
CA2688478C
(en)
|
2007-06-06 |
2015-10-27 |
Debio Recherche Pharmaceutique S.A. |
Slow release pharmaceutical composition made of microparticles
|
RU2010119041A
(ru)
*
|
2007-10-12 |
2011-11-20 |
Такеда Фармасьютикалз Норт Америка, Инк. (Us) |
Способы лечения нарушений желудочно-кишечного тракта, независимого от потребления пищи
|
WO2010009291A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles containing bioactive peptides
|
US20100047292A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Baxter International Inc. |
Methods of processing microparticles and compositions produced thereby
|
US8367427B2
(en)
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US8323615B2
(en)
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
US8323685B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
EP2365802B1
(en)
|
2008-11-11 |
2017-08-02 |
The Board of Regents,The University of Texas System |
Microcapsules of rapamycin and use for treating cancer
|
US9427418B2
(en)
|
2009-02-23 |
2016-08-30 |
Gtx, Inc. |
Estrogen receptor ligands and methods of use thereof
|
US9624161B2
(en)
|
2009-02-23 |
2017-04-18 |
Gtx, Inc. |
Estrogen receptor ligands and methods of use thereof
|
US20100280117A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Xanodyne Pharmaceuticals, Inc. |
Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
|
US9205577B2
(en)
*
|
2010-02-05 |
2015-12-08 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
US9138309B2
(en)
|
2010-02-05 |
2015-09-22 |
Allergan, Inc. |
Porous materials, methods of making and uses
|
US11202853B2
(en)
*
|
2010-05-11 |
2021-12-21 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
WO2012012460A1
(en)
|
2010-07-19 |
2012-01-26 |
Xeris Pharmaceuticals, Inc. |
Stable glucagon formulations for the treatment of hypoglycemia
|
GB201016433D0
(en)
|
2010-09-30 |
2010-11-17 |
Q Chip Ltd |
Apparatus and method for making solid beads
|
GB201016436D0
(en)
|
2010-09-30 |
2010-11-17 |
Q Chip Ltd |
Method of making solid beads
|
SG193389A1
(en)
|
2011-03-10 |
2013-10-30 |
Xeris Pharmaceuticals Inc |
Stable formulations for parenteral injection of peptide drugs
|
KR101481859B1
(ko)
*
|
2011-05-20 |
2015-01-14 |
에스케이케미칼주식회사 |
초기 약물 방출이 감소된 고분자 미립자의 제조방법 및 그 방법에 의해 제조된 고분자 미립자
|
EP2773331B1
(en)
|
2011-10-31 |
2016-02-10 |
Xeris Pharmaceuticals, Inc. |
Formulations for the treatment of diabetes
|
US9125805B2
(en)
|
2012-06-27 |
2015-09-08 |
Xeris Pharmaceuticals, Inc. |
Stable formulations for parenteral injection of small molecule drugs
|
US9018162B2
(en)
|
2013-02-06 |
2015-04-28 |
Xeris Pharmaceuticals, Inc. |
Methods for rapidly treating severe hypoglycemia
|
EP2968281B1
(en)
|
2013-03-13 |
2020-08-05 |
The Board of Regents of The University of Texas System |
Mtor inhibitors for prevention of intestinal polyp growth
|
JP2014223608A
(ja)
*
|
2013-04-17 |
2014-12-04 |
積水化学工業株式会社 |
マイクロカプセルの製造方法及びマイクロカプセル
|
CA3206208A1
(en)
|
2013-12-31 |
2015-07-09 |
Rapamycin Holdings, Llc |
Oral rapamycin nanoparticle preparations and use
|
US11129940B2
(en)
|
2014-08-06 |
2021-09-28 |
Xeris Pharmaceuticals, Inc. |
Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
|
US10865184B2
(en)
|
2015-04-21 |
2020-12-15 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US10035763B2
(en)
|
2015-04-21 |
2018-07-31 |
Gtx, Inc. |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US10093613B2
(en)
|
2015-04-21 |
2018-10-09 |
Gtx, Inc. |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
MX2017013565A
(es)
|
2015-04-21 |
2018-02-19 |
Gtx Inc |
Ligandos degradadores selectivos del receptor androgénico (sard) y sus métodos uso.
|
US9834507B2
(en)
|
2015-04-21 |
2017-12-05 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
KR20170140291A
(ko)
|
2015-04-21 |
2017-12-20 |
지티엑스, 인코포레이티드 |
선택적 안드로겐 수용체 분해제(sard) 리간드 및 이의 사용 방법
|
US10654809B2
(en)
|
2016-06-10 |
2020-05-19 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US10441570B2
(en)
|
2015-04-21 |
2019-10-15 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) Ligands and methods of use thereof
|
US10017471B2
(en)
|
2015-04-21 |
2018-07-10 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US10806720B2
(en)
|
2015-04-21 |
2020-10-20 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US9649364B2
(en)
|
2015-09-25 |
2017-05-16 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic formulations in aprotic polar solvents
|
US20180235924A1
(en)
|
2015-08-20 |
2018-08-23 |
Sol-Gel Technologies Ltd. |
Compositions for topical application comprising benzoyl peroxide and adapalene
|
US11590205B2
(en)
|
2015-09-25 |
2023-02-28 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
|
ES2909565T3
(es)
|
2016-01-31 |
2022-05-09 |
Mediwound Ltd |
Composición desbridante para el tratamiento de heridas
|
WO2017183018A1
(en)
*
|
2016-04-18 |
2017-10-26 |
Mediwound Ltd |
Methods of debridement of chronic wounds
|
US11230523B2
(en)
|
2016-06-10 |
2022-01-25 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
KR102481319B1
(ko)
|
2016-06-10 |
2022-12-26 |
유니버시티 오브 테네시 리서치 파운데이션 |
선택적 안드로겐 수용체 분해제(sard) 리간드 및 이의 사용 방법
|
US10806719B2
(en)
|
2016-06-10 |
2020-10-20 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
CN117085022A
(zh)
|
2017-06-02 |
2023-11-21 |
Xeris药物公司 |
抗沉淀的小分子药物制剂
|
CN110869013A
(zh)
|
2017-07-12 |
2020-03-06 |
索尔-格尔科技有限公司 |
包含囊封的维甲酸的组合物
|
US10420743B2
(en)
|
2017-07-12 |
2019-09-24 |
Sol-Gel Technologies Ltd |
Methods and compositions for the treatment of acne
|
KR20210120819A
(ko)
|
2018-05-16 |
2021-10-07 |
온크터널 테라퓨틱스 인코포레이티드 |
선택적 안드로겐 수용체 분해제(sard) 리간드 및 이의 사용 방법
|
FR3082842A1
(fr)
|
2018-06-21 |
2019-12-27 |
Veru Inc. |
Polymorphe de cis-clomiphene (zuclomiphene) et procedes d'utilisation de celui-ci
|